Guidelines for opioid prescribing in chronic noncancer pain, what is a key principle?

Prepare for the Therapeutics of Pain Test. Study effectively with interactive questions covering key topics in pain management. Boost your confidence with detailed explanations and expert tips for success!

Multiple Choice

Guidelines for opioid prescribing in chronic noncancer pain, what is a key principle?

Explanation:
The key principle is to treat chronic noncancer pain with a cautious, multimodal approach: start with nonopioid and nonpharmacologic therapies, use opioids only when necessary at the lowest effective dose, and monitor closely over time. This mindset reflects evidence that nonopioid and nonpharmacologic options often provide meaningful relief with fewer harms, and that the benefits of long-term opioid use are limited while risks increase with higher doses and longer duration. Pairing opioid therapy with prescription drug monitoring programs helps detect problematic patterns like doctor shopping or undisclosed sedatives, and using risk stratification tools guides how intensively to monitor, counsel, or taper. Regular reassessment of pain, function, quality of life, and risk factors ensures the plan can be adjusted if benefits decline or harms rise. In short, prioritize safer alternatives, keep opioid dosing at the lowest effective level, and maintain vigilant monitoring rather than relying on patient self-report alone or pursuing high-dose, long-term opioid therapy.

The key principle is to treat chronic noncancer pain with a cautious, multimodal approach: start with nonopioid and nonpharmacologic therapies, use opioids only when necessary at the lowest effective dose, and monitor closely over time. This mindset reflects evidence that nonopioid and nonpharmacologic options often provide meaningful relief with fewer harms, and that the benefits of long-term opioid use are limited while risks increase with higher doses and longer duration. Pairing opioid therapy with prescription drug monitoring programs helps detect problematic patterns like doctor shopping or undisclosed sedatives, and using risk stratification tools guides how intensively to monitor, counsel, or taper. Regular reassessment of pain, function, quality of life, and risk factors ensures the plan can be adjusted if benefits decline or harms rise. In short, prioritize safer alternatives, keep opioid dosing at the lowest effective level, and maintain vigilant monitoring rather than relying on patient self-report alone or pursuing high-dose, long-term opioid therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy